Video

AML Treatment Selection: Goals, Tests, and Considerations

Cole McCoy, PharmD, and James McCloskey, MD, explain common treatment goals, cytogenetic tests, and considerations that factor into choosing individualized treatment for patients with AML.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
1 expert in this video
1 expert in this video
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
Hematology -- Image credit: DIgilife | stock.adobe.com
Related Content
Diffuse large B cell lymphoma (DLBCL) -- Image credit: SuriyaPhoto | stock.adobe.com
July 18th 2025

FDA Issues Complete Response Letter for Glofit-GemOx in R/R DLBCL

Gillian McGovern, Associate Editor
pharmacy focus oncology edition
May 12th 2025

Insights from a Pharmacy Times Peer Exchange: Emerging ADCs and Real-World Management

Alexandra Gerlach, Associate Editor
NCCN Flash Update: Updated CML Guidelines Emphasize Distress Screening, Drug Interactions, and Cost
July 18th 2025

NCCN Flash Update: Updated CML Guidelines Emphasize Distress Screening, Drug Interactions, and Cost

Alana Hippensteele, Lead Editor
Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations
April 29th 2025

Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations

Alexandra Gerlach, Associate Editor
Chicago, IL skyline | Image Credit: © rudi1976 - stock.adobe.com
July 16th 2025

Insights From ASCO 2025 Guide Pharmacy Practice in Solid Tumors and Hematologic Cancers

Kevin Chen, PharmD Matthew M. Lei, PharmD, BCOP
3D rendering of a CAR T cell | Image Credit: © furyon - stock.adobe.com
July 15th 2025

Large Real-World Study Validates Idecabtagene Vicleucel Outcomes Seen in KarMMa Trial

Alexandra Gerlach, Associate Editor